The ROE as of December 2024 (TTM) for Rubius Therapeutics, Inc. (RUBY) is -238.11%

According to Rubius Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -238.11%. This represents a change of 54.97% compared to the average of -153.65% of the last 4 quarters.

Rubius Therapeutics, Inc. (RUBY) Historical ROE (quarterly & annually)

How has RUBY ROE performed in the past?

The mean historical ROE of Rubius Therapeutics, Inc. over the last ten years is -237.48%. The current -238.11% ROE has changed 0.27% with respect to the historical average. Over the past ten years (40 quarters), RUBY's ROE was at its highest in in the December 2017 quarter at 40.10%. The ROE was at its lowest in in the December 2022 quarter at -272.85%.

Rubius Therapeutics, Inc. (RUBY) ROE by Quarter and Year

Discovering the peaks and valleys of Rubius Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rubius Therapeutics, Inc. (RUBY) Average ROE

How has RUBY ROE performed in the past?

The current ROE of Rubius Therapeutics, Inc. (RUBY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Rubius Therapeutics, Inc. (RUBY) ROE vs. Peers

How is RUBY’s ROE compared to its peers?

Rubius Therapeutics, Inc.’s ROE is greater than Magenta Therapeutics, Inc. (-14.27%), less than Evelo Biosciences, Inc. (91.90%), less than AVROBIO, Inc. (29.68%), greater than Scholar Rock Holding Corporation (-145.60%), greater than Replimune Group, Inc. (-53.12%),

Build a custom stock screener for Rubius Therapeutics, Inc. (RUBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rubius Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rubius Therapeutics, Inc. (RUBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rubius Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.